Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva

ClinicalTrials.gov ID: NCT00028951

Public ClinicalTrials.gov record NCT00028951. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 9:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Clinical Trial Use of TISSEEL VH Fibrin Sealant to Reduce Lymphedema Incidence After Inguinal Lymph Node Dissection Performed in the Management of Vulvar Malignancies

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Fibrin sealant may decrease lymphedema following surgery to remove lymph nodes in the groin by helping to seal the lymphatic vessels. It is not yet known if fibrin sealant is effective in decreasing lymphedema following surgery to remove lymph nodes. PURPOSE: Randomized phase III trial to determine the effectiveness of fibrin sealant in reducing lymphedema following surgical removal of lymph nodes in patients who have cancer of the vulva.

Study identification

NCT ID
NCT00028951
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2003 (Type not available)
Primary completion
Dec 2005 (Actual)
Completion
Not listed
Last update posted
Jul 9, 2013

Started 2003

United States locations

U.S. sites
49
U.S. states
25
U.S. cities
48
Facility City State ZIP Site status
Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham Alabama 35294 —
CCOP - Western Regional, Arizona Phoenix Arizona 85006-2726 —
Jonsson Comprehensive Cancer Center at UCLA Los Angeles California 90095-1740 —
Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange California 92868 —
University of Colorado Cancer Center at University of Colorado Health Sciences Center Denver Colorado 80010 —
CCOP - Christiana Care Health Services Newark Delaware 19713 —
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307-5001 —
MBCCOP - University of Illinois at Chicago Chicago Illinois 60612 —
CCOP - Central Illinois Decatur Illinois 62794-9640 —
CCOP - Evanston Evanston Illinois 60201 —
CCOP - Carle Cancer Center Urbana Illinois 61801 —
Saint Joseph Regional Medical Center South Bend Indiana 46617 —
Holden Comprehensive Cancer Center at University of Iowa Iowa City Iowa 52242-1002 —
CCOP - Michigan Cancer Research Consortium Ann Arbor Michigan 48106 —
CCOP - Grand Rapids Grand Rapids Michigan 49503 —
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731 —
University of Minnesota Cancer Center Minneapolis Minnesota 55455 —
Mayo Clinic Cancer Center Rochester Minnesota 55905-0001 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
University of Mississippi Medical Center Jackson Mississippi 39216-4505 —
Keesler Medical Center - Keesler Air Force Base Keesler Air Force Base Mississippi 39534-2576 —
Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia Missouri 65203 —
CCOP - Kansas City Kansas City Missouri 64131 —
CCOP - Cancer Research for the Ozarks Springfield Missouri 65807 —
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68106 —
Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees Camden New Jersey 08103-1489 —
Roswell Park Cancer Institute Buffalo New York 14263-0001 —
Memorial Sloan-Kettering Cancer Center New York New York 10021 —
Long Island Cancer Center at Stony Brook University Hospital Stony Brook New York 11790-7775 —
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599-7570 —
Duke Comprehensive Cancer Center Durham North Carolina 27710 —
Comprehensive Cancer Center at Wake Forest University Winston-Salem North Carolina 27157-1065 —
Charles M. Barrett Cancer Center at University Hospital Cincinnati Ohio 45267-0520 —
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44124 —
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus Ohio 43210-1240 —
University of Oklahoma College of Medicine Oklahoma City Oklahoma 73104 —
Oklahoma University Medical Center Oklahoma City Oklahoma 73190 —
CCOP - Columbia River Oncology Program Portland Oregon 97225 —
Abington Memorial Hospital Abington Pennsylvania 19001-3788 —
CCOP - Geisinger Clinic and Medical Center Danville Pennsylvania 17822-2001 —
Fox Chase-Temple Cancer Center Philadelphia Pennsylvania 19111 —
UPMC Cancer Center at Magee-Womens Hospital Pittsburgh Pennsylvania 15213-3180 —
Southeast Gynecologic Oncology Associates Knoxville Tennessee 37917 —
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232-2516 —
University of Texas Medical Branch Galveston Texas 77555-0587 —
M.D. Anderson Cancer Center at University of Texas Houston Texas 77030-4009 —
CCOP - Scott and White Hospital Temple Texas 76508 —
Fletcher Allen Health Care - Medical Center Hospital of Vermont Campus Burlington Vermont 05401 —
MultiCare Regional Cancer Center at Tacoma General Hospital Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00028951, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 9, 2013 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00028951 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →